I could have asked you the same question the other day when we sold off.. what has changed?
Answer: nothing:)
We still have the RBLs going to bat for us.. We still have statistically signifcant data to back up the Grant application.. We still are looking forward to an eventual FUNDED trial for COVID.. We are still looking forward to Peer Reviews.. We are still looking forward to additional data that will probably inform the above human trial.. We still have all of the other indications for B that the company is still working on..
Small but adequate FDA trial phaseIi would cost between $2-$4M. But that would not necessarily be the cost for IPIX. Grant and shared costs are common. A research hospital with a specific interest in Brilacidin could pay for the entire cost except for the supplying of the drug in the form requested, i e. IV, Pill, or mist Inhaler. The latter would likely involve the research hospital paying the full boat.
Of course all above without considering IPIX being awarded Grant monies.
I have no worries regarding getting to the finish line on current $6M.